FHIR IG analytics

Resources that use this resource

No resources found

Resources that this resource uses

No resources found

Narrative

Note: links and images are rebased to the (stated) source

Source1

{
  "resourceType": "Composition",
  "id": "399872",
  "meta": {
    "versionId": "5",
    "lastUpdated": "2025-12-11T20:35:21.032Z",
    "profile": [
      "http://hl7.org/fhir/uv/ebm/StructureDefinition/baseline-measure-report"
    ]
  },
  "language": "en",
  "text": {
    "status": "extensions",
    "div": "<!-- snip (see above) -->"
  },
  "contained": [
    {
      "resourceType": "EvidenceVariable",
      "id": "NCT03421379-BaselineMeasure-0",
      "meta": {
        "profile": [
          "http://hl7.org/fhir/uv/ebm/StructureDefinition/variable-definition"
        ]
      },
      "extension": [
        {
          "url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/evidence-variable-handling-detail",
          "valueCodeableConcept": {
            "coding": [
              {
                "system": "https://fevir.net/resources/CodeSystem/179423",
                "code": "evidence-variable-handling-not-specified",
                "display": "Evidence variable handling not specified"
              }
            ]
          }
        }
      ],
      "title": "Age, Continuous",
      "status": "active",
      "definition": {
        "concept": {
          "text": "Age, Continuous"
        }
      },
      "handling": "extension",
      "classifier": [
        {
          "text": "Baseline Measure"
        }
      ],
      "timing": {
        "offsetDuration": {
          "value": 0
        }
      }
    },
    {
      "resourceType": "EvidenceVariable",
      "id": "NCT03421379-BaselineMeasure-1",
      "meta": {
        "profile": [
          "http://hl7.org/fhir/uv/ebm/StructureDefinition/variable-definition"
        ]
      },
      "extension": [
        {
          "url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/evidence-variable-handling-detail",
          "valueCodeableConcept": {
            "coding": [
              {
                "system": "https://fevir.net/resources/CodeSystem/179423",
                "code": "evidence-variable-handling-not-specified",
                "display": "Evidence variable handling not specified"
              }
            ]
          }
        }
      ],
      "title": "Sex: Female, Male",
      "status": "active",
      "definition": {
        "concept": {
          "text": "Sex: Female, Male"
        }
      },
      "handling": "extension",
      "category": [
        {
          "name": "Female"
        },
        {
          "name": "Male"
        }
      ],
      "classifier": [
        {
          "text": "Baseline Measure"
        }
      ],
      "timing": {
        "offsetDuration": {
          "value": 0
        }
      }
    },
    {
      "resourceType": "EvidenceVariable",
      "id": "NCT03421379-BaselineMeasure-2",
      "meta": {
        "profile": [
          "http://hl7.org/fhir/uv/ebm/StructureDefinition/variable-definition"
        ]
      },
      "extension": [
        {
          "url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/evidence-variable-handling-detail",
          "valueCodeableConcept": {
            "coding": [
              {
                "system": "https://fevir.net/resources/CodeSystem/179423",
                "code": "evidence-variable-handling-not-specified",
                "display": "Evidence variable handling not specified"
              }
            ]
          }
        }
      ],
      "title": "Ethnicity (NIH/OMB)",
      "status": "active",
      "definition": {
        "concept": {
          "text": "Ethnicity (NIH/OMB)"
        }
      },
      "handling": "extension",
      "category": [
        {
          "name": "Hispanic or Latino"
        },
        {
          "name": "Not Hispanic or Latino"
        },
        {
          "name": "Unknown or Not Reported"
        }
      ],
      "classifier": [
        {
          "text": "Baseline Measure"
        }
      ],
      "timing": {
        "offsetDuration": {
          "value": 0
        }
      }
    },
    {
      "resourceType": "EvidenceVariable",
      "id": "NCT03421379-BaselineMeasure-3",
      "meta": {
        "profile": [
          "http://hl7.org/fhir/uv/ebm/StructureDefinition/variable-definition"
        ]
      },
      "extension": [
        {
          "url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/evidence-variable-handling-detail",
          "valueCodeableConcept": {
            "coding": [
              {
                "system": "https://fevir.net/resources/CodeSystem/179423",
                "code": "evidence-variable-handling-not-specified",
                "display": "Evidence variable handling not specified"
              }
            ]
          }
        }
      ],
      "title": "Race (NIH/OMB)",
      "status": "active",
      "definition": {
        "concept": {
          "text": "Race (NIH/OMB)"
        }
      },
      "handling": "extension",
      "category": [
        {
          "name": "American Indian or Alaska Native"
        },
        {
          "name": "Asian"
        },
        {
          "name": "Native Hawaiian or Other Pacific Islander"
        },
        {
          "name": "Black or African American"
        },
        {
          "name": "White"
        },
        {
          "name": "More than one race"
        },
        {
          "name": "Unknown or Not Reported"
        }
      ],
      "classifier": [
        {
          "text": "Baseline Measure"
        }
      ],
      "timing": {
        "offsetDuration": {
          "value": 0
        }
      }
    },
    {
      "resourceType": "EvidenceVariable",
      "id": "NCT03421379-BaselineMeasure-4",
      "meta": {
        "profile": [
          "http://hl7.org/fhir/uv/ebm/StructureDefinition/variable-definition"
        ]
      },
      "extension": [
        {
          "url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/evidence-variable-handling-detail",
          "valueCodeableConcept": {
            "coding": [
              {
                "system": "https://fevir.net/resources/CodeSystem/179423",
                "code": "evidence-variable-handling-not-specified",
                "display": "Evidence variable handling not specified"
              }
            ]
          }
        }
      ],
      "title": "Region of Enrollment",
      "status": "active",
      "definition": {
        "concept": {
          "text": "Region of Enrollment"
        }
      },
      "handling": "extension",
      "category": [
        {
          "name": "Japan"
        }
      ],
      "classifier": [
        {
          "text": "Baseline Measure"
        }
      ],
      "timing": {
        "offsetDuration": {
          "value": 0
        }
      }
    },
    {
      "resourceType": "Group",
      "id": "BG000",
      "meta": {
        "profile": [
          "http://hl7.org/fhir/uv/ebm/StructureDefinition/exposure-group"
        ]
      },
      "name": "Glucagon Nasal Powder/Glucagon Hydrochloride Solution",
      "description": "A single dose of 3 mg glucagon nasal powder was administered intranasally",
      "type": "person",
      "membership": "enumerated",
      "code": {
        "text": "Participants"
      },
      "quantity": 33,
      "characteristic": [
        {
          "code": {
            "text": "Research Study from which this is a baseline group"
          },
          "valueReference": {
            "display": "NCT03421379"
          },
          "exclude": false
        }
      ]
    },
    {
      "resourceType": "Group",
      "id": "BG001",
      "meta": {
        "profile": [
          "http://hl7.org/fhir/uv/ebm/StructureDefinition/exposure-group"
        ]
      },
      "name": "Glucagon Hydrochloride Solution/Glucagon Nasal Powder",
      "description": "A single dose of 1 mg glucagon hydrochloride solution was administered IM",
      "type": "person",
      "membership": "enumerated",
      "code": {
        "text": "Participants"
      },
      "quantity": 39,
      "characteristic": [
        {
          "code": {
            "text": "Research Study from which this is a baseline group"
          },
          "valueReference": {
            "display": "NCT03421379"
          },
          "exclude": false
        }
      ]
    },
    {
      "resourceType": "Group",
      "id": "BG002",
      "meta": {
        "profile": [
          "http://hl7.org/fhir/uv/ebm/StructureDefinition/exposure-group"
        ]
      },
      "name": "Total",
      "description": "Total of all reporting groups",
      "type": "person",
      "membership": "enumerated",
      "code": {
        "text": "Participants"
      },
      "quantity": 72,
      "characteristic": [
        {
          "code": {
            "text": "Research Study from which this is a baseline group"
          },
          "valueReference": {
            "display": "NCT03421379"
          },
          "exclude": false
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "NCT03421379-BaselineMeasure-0-BG000",
      "meta": {
        "profile": [
          "http://hl7.org/fhir/uv/ebm/StructureDefinition/non-comparative-evidence"
        ]
      },
      "name": "NCT03421379_BaselineMeasure_0_BG000",
      "title": "Age, Continuous for Glucagon Nasal Powder/Glucagon Hydrochloride Solution at baseline in NCT03421379",
      "status": "active",
      "variableDefinition": [
        {
          "note": [
            {
              "text": "Baseline Reporting Population Description: All randomized participants who received at least one dose of study drug."
            }
          ],
          "variableRole": "population",
          "observed": {
            "reference": "#BG000",
            "type": "Group",
            "display": "Glucagon Nasal Powder/Glucagon Hydrochloride Solution"
          }
        },
        {
          "variableRole": "outcome",
          "observed": {
            "reference": "#NCT03421379-BaselineMeasure-0",
            "type": "EvidenceVariable",
            "display": "Age, Continuous"
          }
        }
      ],
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "https://fevir.net/sevco",
                "code": "STATO:0000573",
                "display": "mean"
              }
            ]
          },
          "quantity": {
            "value": 41.7,
            "unit": "years"
          },
          "sampleSize": {
            "knownDataCount": 33
          },
          "attributeEstimate": [
            {
              "type": {
                "text": "Standard Deviation"
              },
              "quantity": {
                "value": 11.6,
                "unit": "years"
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "NCT03421379-BaselineMeasure-0-BG001",
      "meta": {
        "profile": [
          "http://hl7.org/fhir/uv/ebm/StructureDefinition/non-comparative-evidence"
        ]
      },
      "name": "NCT03421379_BaselineMeasure_0_BG001",
      "title": "Age, Continuous for Glucagon Hydrochloride Solution/Glucagon Nasal Powder at baseline in NCT03421379",
      "status": "active",
      "variableDefinition": [
        {
          "note": [
            {
              "text": "Baseline Reporting Population Description: All randomized participants who received at least one dose of study drug."
            }
          ],
          "variableRole": "population",
          "observed": {
            "reference": "#BG001",
            "type": "Group",
            "display": "Glucagon Hydrochloride Solution/Glucagon Nasal Powder"
          }
        },
        {
          "variableRole": "outcome",
          "observed": {
            "reference": "#NCT03421379-BaselineMeasure-0",
            "type": "EvidenceVariable",
            "display": "Age, Continuous"
          }
        }
      ],
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "https://fevir.net/sevco",
                "code": "STATO:0000573",
                "display": "mean"
              }
            ]
          },
          "quantity": {
            "value": 57.5,
            "unit": "years"
          },
          "sampleSize": {
            "knownDataCount": 39
          },
          "attributeEstimate": [
            {
              "type": {
                "text": "Standard Deviation"
              },
              "quantity": {
                "value": 9.2,
                "unit": "years"
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "NCT03421379-BaselineMeasure-0-BG002",
      "meta": {
        "profile": [
          "http://hl7.org/fhir/uv/ebm/StructureDefinition/non-comparative-evidence"
        ]
      },
      "name": "NCT03421379_BaselineMeasure_0_BG002",
      "title": "Age, Continuous for Total at baseline in NCT03421379",
      "status": "active",
      "variableDefinition": [
        {
          "note": [
            {
              "text": "Baseline Reporting Population Description: All randomized participants who received at least one dose of study drug."
            }
          ],
          "variableRole": "population",
          "observed": {
            "reference": "#BG002",
            "type": "Group",
            "display": "Total"
          }
        },
        {
          "variableRole": "outcome",
          "observed": {
            "reference": "#NCT03421379-BaselineMeasure-0",
            "type": "EvidenceVariable",
            "display": "Age, Continuous"
          }
        }
      ],
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "https://fevir.net/sevco",
                "code": "STATO:0000573",
                "display": "mean"
              }
            ]
          },
          "quantity": {
            "value": 50.2,
            "unit": "years"
          },
          "sampleSize": {
            "knownDataCount": 72
          },
          "attributeEstimate": [
            {
              "type": {
                "text": "Standard Deviation"
              },
              "quantity": {
                "value": 13,
                "unit": "years"
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "NCT03421379-BaselineMeasure-1-BG000",
      "meta": {
        "profile": [
          "http://hl7.org/fhir/uv/ebm/StructureDefinition/non-comparative-evidence"
        ]
      },
      "name": "NCT03421379_BaselineMeasure_1_BG000",
      "title": "Sex: Female, Male for Glucagon Nasal Powder/Glucagon Hydrochloride Solution at baseline in NCT03421379",
      "status": "active",
      "variableDefinition": [
        {
          "note": [
            {
              "text": "Baseline Reporting Population Description: All randomized participants who received at least one dose of study drug."
            }
          ],
          "variableRole": "population",
          "observed": {
            "reference": "#BG000",
            "type": "Group",
            "display": "Glucagon Nasal Powder/Glucagon Hydrochloride Solution"
          }
        },
        {
          "variableRole": "outcome",
          "observed": {
            "reference": "#NCT03421379-BaselineMeasure-1",
            "type": "EvidenceVariable",
            "display": "Sex: Female, Male"
          }
        }
      ],
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "https://fevir.net/sevco",
                "code": "STATO:0000047",
                "display": "count"
              }
            ],
            "text": "Count of Participants"
          },
          "category": {
            "text": "Female"
          },
          "quantity": {
            "value": 13,
            "unit": "Participants"
          },
          "sampleSize": {
            "knownDataCount": 33
          }
        },
        {
          "statisticType": {
            "coding": [
              {
                "system": "https://fevir.net/sevco",
                "code": "STATO:0000047",
                "display": "count"
              }
            ],
            "text": "Count of Participants"
          },
          "category": {
            "text": "Male"
          },
          "quantity": {
            "value": 20,
            "unit": "Participants"
          },
          "sampleSize": {
            "knownDataCount": 33
          }
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "NCT03421379-BaselineMeasure-1-BG001",
      "meta": {
        "profile": [
          "http://hl7.org/fhir/uv/ebm/StructureDefinition/non-comparative-evidence"
        ]
      },
      "name": "NCT03421379_BaselineMeasure_1_BG001",
      "title": "Sex: Female, Male for Glucagon Hydrochloride Solution/Glucagon Nasal Powder at baseline in NCT03421379",
      "status": "active",
      "variableDefinition": [
        {
          "note": [
            {
              "text": "Baseline Reporting Population Description: All randomized participants who received at least one dose of study drug."
            }
          ],
          "variableRole": "population",
          "observed": {
            "reference": "#BG001",
            "type": "Group",
            "display": "Glucagon Hydrochloride Solution/Glucagon Nasal Powder"
          }
        },
        {
          "variableRole": "outcome",
          "observed": {
            "reference": "#NCT03421379-BaselineMeasure-1",
            "type": "EvidenceVariable",
            "display": "Sex: Female, Male"
          }
        }
      ],
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "https://fevir.net/sevco",
                "code": "STATO:0000047",
                "display": "count"
              }
            ],
            "text": "Count of Participants"
          },
          "category": {
            "text": "Female"
          },
          "quantity": {
            "value": 9,
            "unit": "Participants"
          },
          "sampleSize": {
            "knownDataCount": 39
          }
        },
        {
          "statisticType": {
            "coding": [
              {
                "system": "https://fevir.net/sevco",
                "code": "STATO:0000047",
                "display": "count"
              }
            ],
            "text": "Count of Participants"
          },
          "category": {
            "text": "Male"
          },
          "quantity": {
            "value": 30,
            "unit": "Participants"
          },
          "sampleSize": {
            "knownDataCount": 39
          }
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "NCT03421379-BaselineMeasure-1-BG002",
      "meta": {
        "profile": [
          "http://hl7.org/fhir/uv/ebm/StructureDefinition/non-comparative-evidence"
        ]
      },
      "name": "NCT03421379_BaselineMeasure_1_BG002",
      "title": "Sex: Female, Male for Total at baseline in NCT03421379",
      "status": "active",
      "variableDefinition": [
        {
          "note": [
            {
              "text": "Baseline Reporting Population Description: All randomized participants who received at least one dose of study drug."
            }
          ],
          "variableRole": "population",
          "observed": {
            "reference": "#BG002",
            "type": "Group",
            "display": "Total"
          }
        },
        {
          "variableRole": "outcome",
          "observed": {
            "reference": "#NCT03421379-BaselineMeasure-1",
            "type": "EvidenceVariable",
            "display": "Sex: Female, Male"
          }
        }
      ],
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "https://fevir.net/sevco",
                "code": "STATO:0000047",
                "display": "count"
              }
            ],
            "text": "Count of Participants"
          },
          "category": {
            "text": "Female"
          },
          "quantity": {
            "value": 22,
            "unit": "Participants"
          },
          "sampleSize": {
            "knownDataCount": 72
          }
        },
        {
          "statisticType": {
            "coding": [
              {
                "system": "https://fevir.net/sevco",
                "code": "STATO:0000047",
                "display": "count"
              }
            ],
            "text": "Count of Participants"
          },
          "category": {
            "text": "Male"
          },
          "quantity": {
            "value": 50,
            "unit": "Participants"
          },
          "sampleSize": {
            "knownDataCount": 72
          }
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "NCT03421379-BaselineMeasure-2-BG000",
      "meta": {
        "profile": [
          "http://hl7.org/fhir/uv/ebm/StructureDefinition/non-comparative-evidence"
        ]
      },
      "name": "NCT03421379_BaselineMeasure_2_BG000",
      "title": "Ethnicity (NIH/OMB) for Glucagon Nasal Powder/Glucagon Hydrochloride Solution at baseline in NCT03421379",
      "status": "active",
      "variableDefinition": [
        {
          "note": [
            {
              "text": "Baseline Reporting Population Description: All randomized participants who received at least one dose of study drug."
            }
          ],
          "variableRole": "population",
          "observed": {
            "reference": "#BG000",
            "type": "Group",
            "display": "Glucagon Nasal Powder/Glucagon Hydrochloride Solution"
          }
        },
        {
          "variableRole": "outcome",
          "observed": {
            "reference": "#NCT03421379-BaselineMeasure-2",
            "type": "EvidenceVariable",
            "display": "Ethnicity (NIH/OMB)"
          }
        }
      ],
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "https://fevir.net/sevco",
                "code": "STATO:0000047",
                "display": "count"
              }
            ],
            "text": "Count of Participants"
          },
          "category": {
            "text": "Hispanic or Latino"
          },
          "quantity": {
            "value": 0,
            "unit": "Participants"
          },
          "sampleSize": {
            "knownDataCount": 33
          }
        },
        {
          "statisticType": {
            "coding": [
              {
                "system": "https://fevir.net/sevco",
                "code": "STATO:0000047",
                "display": "count"
              }
            ],
            "text": "Count of Participants"
          },
          "category": {
            "text": "Not Hispanic or Latino"
          },
          "quantity": {
            "value": 33,
            "unit": "Participants"
          },
          "sampleSize": {
            "knownDataCount": 33
          }
        },
        {
          "statisticType": {
            "coding": [
              {
                "system": "https://fevir.net/sevco",
                "code": "STATO:0000047",
                "display": "count"
              }
            ],
            "text": "Count of Participants"
          },
          "category": {
            "text": "Unknown or Not Reported"
          },
          "quantity": {
            "value": 0,
            "unit": "Participants"
          },
          "sampleSize": {
            "knownDataCount": 33
          }
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "NCT03421379-BaselineMeasure-2-BG001",
      "meta": {
        "profile": [
          "http://hl7.org/fhir/uv/ebm/StructureDefinition/non-comparative-evidence"
        ]
      },
      "name": "NCT03421379_BaselineMeasure_2_BG001",
      "title": "Ethnicity (NIH/OMB) for Glucagon Hydrochloride Solution/Glucagon Nasal Powder at baseline in NCT03421379",
      "status": "active",
      "variableDefinition": [
        {
          "note": [
            {
              "text": "Baseline Reporting Population Description: All randomized participants who received at least one dose of study drug."
            }
          ],
          "variableRole": "population",
          "observed": {
            "reference": "#BG001",
            "type": "Group",
            "display": "Glucagon Hydrochloride Solution/Glucagon Nasal Powder"
          }
        },
        {
          "variableRole": "outcome",
          "observed": {
            "reference": "#NCT03421379-BaselineMeasure-2",
            "type": "EvidenceVariable",
            "display": "Ethnicity (NIH/OMB)"
          }
        }
      ],
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "https://fevir.net/sevco",
                "code": "STATO:0000047",
                "display": "count"
              }
            ],
            "text": "Count of Participants"
          },
          "category": {
            "text": "Hispanic or Latino"
          },
          "quantity": {
            "value": 0,
            "unit": "Participants"
          },
          "sampleSize": {
            "knownDataCount": 39
          }
        },
        {
          "statisticType": {
            "coding": [
              {
                "system": "https://fevir.net/sevco",
                "code": "STATO:0000047",
                "display": "count"
              }
            ],
            "text": "Count of Participants"
          },
          "category": {
            "text": "Not Hispanic or Latino"
          },
          "quantity": {
            "value": 39,
            "unit": "Participants"
          },
          "sampleSize": {
            "knownDataCount": 39
          }
        },
        {
          "statisticType": {
            "coding": [
              {
                "system": "https://fevir.net/sevco",
                "code": "STATO:0000047",
                "display": "count"
              }
            ],
            "text": "Count of Participants"
          },
          "category": {
            "text": "Unknown or Not Reported"
          },
          "quantity": {
            "value": 0,
            "unit": "Participants"
          },
          "sampleSize": {
            "knownDataCount": 39
          }
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "NCT03421379-BaselineMeasure-2-BG002",
      "meta": {
        "profile": [
          "http://hl7.org/fhir/uv/ebm/StructureDefinition/non-comparative-evidence"
        ]
      },
      "name": "NCT03421379_BaselineMeasure_2_BG002",
      "title": "Ethnicity (NIH/OMB) for Total at baseline in NCT03421379",
      "status": "active",
      "variableDefinition": [
        {
          "note": [
            {
              "text": "Baseline Reporting Population Description: All randomized participants who received at least one dose of study drug."
            }
          ],
          "variableRole": "population",
          "observed": {
            "reference": "#BG002",
            "type": "Group",
            "display": "Total"
          }
        },
        {
          "variableRole": "outcome",
          "observed": {
            "reference": "#NCT03421379-BaselineMeasure-2",
            "type": "EvidenceVariable",
            "display": "Ethnicity (NIH/OMB)"
          }
        }
      ],
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "https://fevir.net/sevco",
                "code": "STATO:0000047",
                "display": "count"
              }
            ],
            "text": "Count of Participants"
          },
          "category": {
            "text": "Hispanic or Latino"
          },
          "quantity": {
            "value": 0,
            "unit": "Participants"
          },
          "sampleSize": {
            "knownDataCount": 72
          }
        },
        {
          "statisticType": {
            "coding": [
              {
                "system": "https://fevir.net/sevco",
                "code": "STATO:0000047",
                "display": "count"
              }
            ],
            "text": "Count of Participants"
          },
          "category": {
            "text": "Not Hispanic or Latino"
          },
          "quantity": {
            "value": 72,
            "unit": "Participants"
          },
          "sampleSize": {
            "knownDataCount": 72
          }
        },
        {
          "statisticType": {
            "coding": [
              {
                "system": "https://fevir.net/sevco",
                "code": "STATO:0000047",
                "display": "count"
              }
            ],
            "text": "Count of Participants"
          },
          "category": {
            "text": "Unknown or Not Reported"
          },
          "quantity": {
            "value": 0,
            "unit": "Participants"
          },
          "sampleSize": {
            "knownDataCount": 72
          }
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "NCT03421379-BaselineMeasure-3-BG000",
      "meta": {
        "profile": [
          "http://hl7.org/fhir/uv/ebm/StructureDefinition/non-comparative-evidence"
        ]
      },
      "name": "NCT03421379_BaselineMeasure_3_BG000",
      "title": "Race (NIH/OMB) for Glucagon Nasal Powder/Glucagon Hydrochloride Solution at baseline in NCT03421379",
      "status": "active",
      "variableDefinition": [
        {
          "note": [
            {
              "text": "Baseline Reporting Population Description: All randomized participants who received at least one dose of study drug."
            }
          ],
          "variableRole": "population",
          "observed": {
            "reference": "#BG000",
            "type": "Group",
            "display": "Glucagon Nasal Powder/Glucagon Hydrochloride Solution"
          }
        },
        {
          "variableRole": "outcome",
          "observed": {
            "reference": "#NCT03421379-BaselineMeasure-3",
            "type": "EvidenceVariable",
            "display": "Race (NIH/OMB)"
          }
        }
      ],
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "https://fevir.net/sevco",
                "code": "STATO:0000047",
                "display": "count"
              }
            ],
            "text": "Count of Participants"
          },
          "category": {
            "text": "American Indian or Alaska Native"
          },
          "quantity": {
            "value": 0,
            "unit": "Participants"
          },
          "sampleSize": {
            "knownDataCount": 33
          }
        },
        {
          "statisticType": {
            "coding": [
              {
                "system": "https://fevir.net/sevco",
                "code": "STATO:0000047",
                "display": "count"
              }
            ],
            "text": "Count of Participants"
          },
          "category": {
            "text": "Asian"
          },
          "quantity": {
            "value": 33,
            "unit": "Participants"
          },
          "sampleSize": {
            "knownDataCount": 33
          }
        },
        {
          "statisticType": {
            "coding": [
              {
                "system": "https://fevir.net/sevco",
                "code": "STATO:0000047",
                "display": "count"
              }
            ],
            "text": "Count of Participants"
          },
          "category": {
            "text": "Native Hawaiian or Other Pacific Islander"
          },
          "quantity": {
            "value": 0,
            "unit": "Participants"
          },
          "sampleSize": {
            "knownDataCount": 33
          }
        },
        {
          "statisticType": {
            "coding": [
              {
                "system": "https://fevir.net/sevco",
                "code": "STATO:0000047",
                "display": "count"
              }
            ],
            "text": "Count of Participants"
          },
          "category": {
            "text": "Black or African American"
          },
          "quantity": {
            "value": 0,
            "unit": "Participants"
          },
          "sampleSize": {
            "knownDataCount": 33
          }
        },
        {
          "statisticType": {
            "coding": [
              {
                "system": "https://fevir.net/sevco",
                "code": "STATO:0000047",
                "display": "count"
              }
            ],
            "text": "Count of Participants"
          },
          "category": {
            "text": "White"
          },
          "quantity": {
            "value": 0,
            "unit": "Participants"
          },
          "sampleSize": {
            "knownDataCount": 33
          }
        },
        {
          "statisticType": {
            "coding": [
              {
                "system": "https://fevir.net/sevco",
                "code": "STATO:0000047",
                "display": "count"
              }
            ],
            "text": "Count of Participants"
          },
          "category": {
            "text": "More than one race"
          },
          "quantity": {
            "value": 0,
            "unit": "Participants"
          },
          "sampleSize": {
            "knownDataCount": 33
          }
        },
        {
          "statisticType": {
            "coding": [
              {
                "system": "https://fevir.net/sevco",
                "code": "STATO:0000047",
                "display": "count"
              }
            ],
            "text": "Count of Participants"
          },
          "category": {
            "text": "Unknown or Not Reported"
          },
          "quantity": {
            "value": 0,
            "unit": "Participants"
          },
          "sampleSize": {
            "knownDataCount": 33
          }
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "NCT03421379-BaselineMeasure-3-BG001",
      "meta": {
        "profile": [
          "http://hl7.org/fhir/uv/ebm/StructureDefinition/non-comparative-evidence"
        ]
      },
      "name": "NCT03421379_BaselineMeasure_3_BG001",
      "title": "Race (NIH/OMB) for Glucagon Hydrochloride Solution/Glucagon Nasal Powder at baseline in NCT03421379",
      "status": "active",
      "variableDefinition": [
        {
          "note": [
            {
              "text": "Baseline Reporting Population Description: All randomized participants who received at least one dose of study drug."
            }
          ],
          "variableRole": "population",
          "observed": {
            "reference": "#BG001",
            "type": "Group",
            "display": "Glucagon Hydrochloride Solution/Glucagon Nasal Powder"
          }
        },
        {
          "variableRole": "outcome",
          "observed": {
            "reference": "#NCT03421379-BaselineMeasure-3",
            "type": "EvidenceVariable",
            "display": "Race (NIH/OMB)"
          }
        }
      ],
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "https://fevir.net/sevco",
                "code": "STATO:0000047",
                "display": "count"
              }
            ],
            "text": "Count of Participants"
          },
          "category": {
            "text": "American Indian or Alaska Native"
          },
          "quantity": {
            "value": 0,
            "unit": "Participants"
          },
          "sampleSize": {
            "knownDataCount": 39
          }
        },
        {
          "statisticType": {
            "coding": [
              {
                "system": "https://fevir.net/sevco",
                "code": "STATO:0000047",
                "display": "count"
              }
            ],
            "text": "Count of Participants"
          },
          "category": {
            "text": "Asian"
          },
          "quantity": {
            "value": 39,
            "unit": "Participants"
          },
          "sampleSize": {
            "knownDataCount": 39
          }
        },
        {
          "statisticType": {
            "coding": [
              {
                "system": "https://fevir.net/sevco",
                "code": "STATO:0000047",
                "display": "count"
              }
            ],
            "text": "Count of Participants"
          },
          "category": {
            "text": "Native Hawaiian or Other Pacific Islander"
          },
          "quantity": {
            "value": 0,
            "unit": "Participants"
          },
          "sampleSize": {
            "knownDataCount": 39
          }
        },
        {
          "statisticType": {
            "coding": [
              {
                "system": "https://fevir.net/sevco",
                "code": "STATO:0000047",
                "display": "count"
              }
            ],
            "text": "Count of Participants"
          },
          "category": {
            "text": "Black or African American"
          },
          "quantity": {
            "value": 0,
            "unit": "Participants"
          },
          "sampleSize": {
            "knownDataCount": 39
          }
        },
        {
          "statisticType": {
            "coding": [
              {
                "system": "https://fevir.net/sevco",
                "code": "STATO:0000047",
                "display": "count"
              }
            ],
            "text": "Count of Participants"
          },
          "category": {
            "text": "White"
          },
          "quantity": {
            "value": 0,
            "unit": "Participants"
          },
          "sampleSize": {
            "knownDataCount": 39
          }
        },
        {
          "statisticType": {
            "coding": [
              {
                "system": "https://fevir.net/sevco",
                "code": "STATO:0000047",
                "display": "count"
              }
            ],
            "text": "Count of Participants"
          },
          "category": {
            "text": "More than one race"
          },
          "quantity": {
            "value": 0,
            "unit": "Participants"
          },
          "sampleSize": {
            "knownDataCount": 39
          }
        },
        {
          "statisticType": {
            "coding": [
              {
                "system": "https://fevir.net/sevco",
                "code": "STATO:0000047",
                "display": "count"
              }
            ],
            "text": "Count of Participants"
          },
          "category": {
            "text": "Unknown or Not Reported"
          },
          "quantity": {
            "value": 0,
            "unit": "Participants"
          },
          "sampleSize": {
            "knownDataCount": 39
          }
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "NCT03421379-BaselineMeasure-3-BG002",
      "meta": {
        "profile": [
          "http://hl7.org/fhir/uv/ebm/StructureDefinition/non-comparative-evidence"
        ]
      },
      "name": "NCT03421379_BaselineMeasure_3_BG002",
      "title": "Race (NIH/OMB) for Total at baseline in NCT03421379",
      "status": "active",
      "variableDefinition": [
        {
          "note": [
            {
              "text": "Baseline Reporting Population Description: All randomized participants who received at least one dose of study drug."
            }
          ],
          "variableRole": "population",
          "observed": {
            "reference": "#BG002",
            "type": "Group",
            "display": "Total"
          }
        },
        {
          "variableRole": "outcome",
          "observed": {
            "reference": "#NCT03421379-BaselineMeasure-3",
            "type": "EvidenceVariable",
            "display": "Race (NIH/OMB)"
          }
        }
      ],
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "https://fevir.net/sevco",
                "code": "STATO:0000047",
                "display": "count"
              }
            ],
            "text": "Count of Participants"
          },
          "category": {
            "text": "American Indian or Alaska Native"
          },
          "quantity": {
            "value": 0,
            "unit": "Participants"
          },
          "sampleSize": {
            "knownDataCount": 72
          }
        },
        {
          "statisticType": {
            "coding": [
              {
                "system": "https://fevir.net/sevco",
                "code": "STATO:0000047",
                "display": "count"
              }
            ],
            "text": "Count of Participants"
          },
          "category": {
            "text": "Asian"
          },
          "quantity": {
            "value": 72,
            "unit": "Participants"
          },
          "sampleSize": {
            "knownDataCount": 72
          }
        },
        {
          "statisticType": {
            "coding": [
              {
                "system": "https://fevir.net/sevco",
                "code": "STATO:0000047",
                "display": "count"
              }
            ],
            "text": "Count of Participants"
          },
          "category": {
            "text": "Native Hawaiian or Other Pacific Islander"
          },
          "quantity": {
            "value": 0,
            "unit": "Participants"
          },
          "sampleSize": {
            "knownDataCount": 72
          }
        },
        {
          "statisticType": {
            "coding": [
              {
                "system": "https://fevir.net/sevco",
                "code": "STATO:0000047",
                "display": "count"
              }
            ],
            "text": "Count of Participants"
          },
          "category": {
            "text": "Black or African American"
          },
          "quantity": {
            "value": 0,
            "unit": "Participants"
          },
          "sampleSize": {
            "knownDataCount": 72
          }
        },
        {
          "statisticType": {
            "coding": [
              {
                "system": "https://fevir.net/sevco",
                "code": "STATO:0000047",
                "display": "count"
              }
            ],
            "text": "Count of Participants"
          },
          "category": {
            "text": "White"
          },
          "quantity": {
            "value": 0,
            "unit": "Participants"
          },
          "sampleSize": {
            "knownDataCount": 72
          }
        },
        {
          "statisticType": {
            "coding": [
              {
                "system": "https://fevir.net/sevco",
                "code": "STATO:0000047",
                "display": "count"
              }
            ],
            "text": "Count of Participants"
          },
          "category": {
            "text": "More than one race"
          },
          "quantity": {
            "value": 0,
            "unit": "Participants"
          },
          "sampleSize": {
            "knownDataCount": 72
          }
        },
        {
          "statisticType": {
            "coding": [
              {
                "system": "https://fevir.net/sevco",
                "code": "STATO:0000047",
                "display": "count"
              }
            ],
            "text": "Count of Participants"
          },
          "category": {
            "text": "Unknown or Not Reported"
          },
          "quantity": {
            "value": 0,
            "unit": "Participants"
          },
          "sampleSize": {
            "knownDataCount": 72
          }
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "NCT03421379-BaselineMeasure-4-BG000",
      "meta": {
        "profile": [
          "http://hl7.org/fhir/uv/ebm/StructureDefinition/non-comparative-evidence"
        ]
      },
      "name": "NCT03421379_BaselineMeasure_4_BG000",
      "title": "Region of Enrollment for Glucagon Nasal Powder/Glucagon Hydrochloride Solution at baseline in NCT03421379",
      "status": "active",
      "variableDefinition": [
        {
          "note": [
            {
              "text": "Baseline Reporting Population Description: All randomized participants who received at least one dose of study drug."
            }
          ],
          "variableRole": "population",
          "observed": {
            "reference": "#BG000",
            "type": "Group",
            "display": "Glucagon Nasal Powder/Glucagon Hydrochloride Solution"
          }
        },
        {
          "variableRole": "outcome",
          "observed": {
            "reference": "#NCT03421379-BaselineMeasure-4",
            "type": "EvidenceVariable",
            "display": "Region of Enrollment"
          }
        }
      ],
      "statistic": [
        {
          "statisticType": {
            "text": "Number (see protocol for details)"
          },
          "category": {
            "text": "Japan"
          },
          "quantity": {
            "value": 33,
            "unit": "participants"
          },
          "sampleSize": {
            "knownDataCount": 33
          }
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "NCT03421379-BaselineMeasure-4-BG001",
      "meta": {
        "profile": [
          "http://hl7.org/fhir/uv/ebm/StructureDefinition/non-comparative-evidence"
        ]
      },
      "name": "NCT03421379_BaselineMeasure_4_BG001",
      "title": "Region of Enrollment for Glucagon Hydrochloride Solution/Glucagon Nasal Powder at baseline in NCT03421379",
      "status": "active",
      "variableDefinition": [
        {
          "note": [
            {
              "text": "Baseline Reporting Population Description: All randomized participants who received at least one dose of study drug."
            }
          ],
          "variableRole": "population",
          "observed": {
            "reference": "#BG001",
            "type": "Group",
            "display": "Glucagon Hydrochloride Solution/Glucagon Nasal Powder"
          }
        },
        {
          "variableRole": "outcome",
          "observed": {
            "reference": "#NCT03421379-BaselineMeasure-4",
            "type": "EvidenceVariable",
            "display": "Region of Enrollment"
          }
        }
      ],
      "statistic": [
        {
          "statisticType": {
            "text": "Number (see protocol for details)"
          },
          "category": {
            "text": "Japan"
          },
          "quantity": {
            "value": 39,
            "unit": "participants"
          },
          "sampleSize": {
            "knownDataCount": 39
          }
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "NCT03421379-BaselineMeasure-4-BG002",
      "meta": {
        "profile": [
          "http://hl7.org/fhir/uv/ebm/StructureDefinition/non-comparative-evidence"
        ]
      },
      "name": "NCT03421379_BaselineMeasure_4_BG002",
      "title": "Region of Enrollment for Total at baseline in NCT03421379",
      "status": "active",
      "variableDefinition": [
        {
          "note": [
            {
              "text": "Baseline Reporting Population Description: All randomized participants who received at least one dose of study drug."
            }
          ],
          "variableRole": "population",
          "observed": {
            "reference": "#BG002",
            "type": "Group",
            "display": "Total"
          }
        },
        {
          "variableRole": "outcome",
          "observed": {
            "reference": "#NCT03421379-BaselineMeasure-4",
            "type": "EvidenceVariable",
            "display": "Region of Enrollment"
          }
        }
      ],
      "statistic": [
        {
          "statisticType": {
            "text": "Number (see protocol for details)"
          },
          "category": {
            "text": "Japan"
          },
          "quantity": {
            "value": 72,
            "unit": "participants"
          },
          "sampleSize": {
            "knownDataCount": 72
          }
        }
      ]
    }
  ],
  "url": "https://fevir.net/resources/Composition/399872",
  "identifier": [
    {
      "type": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/v2-0203",
            "code": "ACSN",
            "display": "Accession ID"
          }
        ],
        "text": "FEvIR Object Identifier"
      },
      "system": "https://fevir.net/FOI",
      "value": "399872",
      "assigner": {
        "display": "Computable Publishing LLC"
      }
    },
    {
      "type": {
        "text": "FEvIR Linking Identifier"
      },
      "system": "https://fevir.net/FLI",
      "value": "NCT03421379-baseline-measure-report",
      "assigner": {
        "display": "Computable Publishing LLC"
      }
    }
  ],
  "status": "final",
  "type": {
    "coding": [
      {
        "system": "https://fevir.net/resources/CodeSystem/179423",
        "code": "BaselineMeasureReport",
        "display": "BaselineMeasureReport"
      }
    ],
    "text": "Baseline Measure Report"
  },
  "date": "2025-12-11T20:35:21.032Z",
  "author": [
    {
      "display": "[No author listed.]"
    }
  ],
  "title": "Baseline Characteristics Report for NCT03421379",
  "custodian": {
    "reference": "Organization/118079",
    "type": "Organization",
    "display": "Computable Publishing LLC"
  },
  "relatesTo": [
    {
      "type": "cite-as",
      "targetMarkdown": "Baseline Characteristics Report for NCT03421379 [Database Entry: FHIR Composition Resource]. Contributors: [No author listed.] [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 399872. Revised 2025-12-11. Available at: https://fevir.net/resources/Composition/399872. Computable resource at: https://fevir.net/resources/Composition/399872#json."
    }
  ],
  "section": [
    {
      "title": "Baseline Reporting Population Description",
      "code": {
        "text": "BaselinePopulationDescription"
      },
      "text": {
        "status": "generated",
        "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">All randomized participants who received at least one dose of study drug.</div>"
      }
    },
    {
      "title": "Baseline Group List",
      "code": {
        "text": "BaselineGroupList"
      },
      "text": {
        "status": "generated",
        "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">Glucagon Nasal Powder/Glucagon Hydrochloride Solution, Glucagon Hydrochloride Solution/Glucagon Nasal Powder, Total</div>"
      },
      "entry": [
        {
          "reference": "#BG000",
          "type": "Group",
          "display": "Glucagon Nasal Powder/Glucagon Hydrochloride Solution"
        },
        {
          "reference": "#BG001",
          "type": "Group",
          "display": "Glucagon Hydrochloride Solution/Glucagon Nasal Powder"
        },
        {
          "reference": "#BG002",
          "type": "Group",
          "display": "Total"
        }
      ]
    },
    {
      "title": "Age, Continuous",
      "code": {
        "coding": [
          {
            "system": "https://fevir.net/resources/CodeSystem/179423",
            "code": "results",
            "display": "Results"
          }
        ]
      },
      "focus": {
        "reference": "#NCT03421379-BaselineMeasure-0",
        "type": "EvidenceVariable",
        "display": "Age, Continuous"
      },
      "text": {
        "status": "empty",
        "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No data.]</p></div>"
      },
      "entry": [
        {
          "reference": "#NCT03421379-BaselineMeasure-0-BG000",
          "type": "Evidence",
          "display": "Age, Continuous for Glucagon Nasal Powder/Glucagon Hydrochloride Solution at baseline in NCT03421379"
        },
        {
          "reference": "#NCT03421379-BaselineMeasure-0-BG001",
          "type": "Evidence",
          "display": "Age, Continuous for Glucagon Hydrochloride Solution/Glucagon Nasal Powder at baseline in NCT03421379"
        },
        {
          "reference": "#NCT03421379-BaselineMeasure-0-BG002",
          "type": "Evidence",
          "display": "Age, Continuous for Total at baseline in NCT03421379"
        }
      ]
    },
    {
      "title": "Sex: Female, Male",
      "code": {
        "coding": [
          {
            "system": "https://fevir.net/resources/CodeSystem/179423",
            "code": "results",
            "display": "Results"
          }
        ]
      },
      "focus": {
        "reference": "#NCT03421379-BaselineMeasure-1",
        "type": "EvidenceVariable",
        "display": "Sex: Female, Male"
      },
      "text": {
        "status": "empty",
        "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No data.]</p></div>"
      },
      "entry": [
        {
          "reference": "#NCT03421379-BaselineMeasure-1-BG000",
          "type": "Evidence",
          "display": "Sex: Female, Male for Glucagon Nasal Powder/Glucagon Hydrochloride Solution at baseline in NCT03421379"
        },
        {
          "reference": "#NCT03421379-BaselineMeasure-1-BG001",
          "type": "Evidence",
          "display": "Sex: Female, Male for Glucagon Hydrochloride Solution/Glucagon Nasal Powder at baseline in NCT03421379"
        },
        {
          "reference": "#NCT03421379-BaselineMeasure-1-BG002",
          "type": "Evidence",
          "display": "Sex: Female, Male for Total at baseline in NCT03421379"
        }
      ],
      "section": [
        {
          "title": "Baseline Measure Calculate Percent",
          "code": {
            "text": "BaselineMeasureCalculatePct"
          },
          "text": {
            "status": "generated",
            "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">False</div>"
          }
        }
      ]
    },
    {
      "title": "Ethnicity (NIH/OMB)",
      "code": {
        "coding": [
          {
            "system": "https://fevir.net/resources/CodeSystem/179423",
            "code": "results",
            "display": "Results"
          }
        ]
      },
      "focus": {
        "reference": "#NCT03421379-BaselineMeasure-2",
        "type": "EvidenceVariable",
        "display": "Ethnicity (NIH/OMB)"
      },
      "text": {
        "status": "empty",
        "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No data.]</p></div>"
      },
      "entry": [
        {
          "reference": "#NCT03421379-BaselineMeasure-2-BG000",
          "type": "Evidence",
          "display": "Ethnicity (NIH/OMB) for Glucagon Nasal Powder/Glucagon Hydrochloride Solution at baseline in NCT03421379"
        },
        {
          "reference": "#NCT03421379-BaselineMeasure-2-BG001",
          "type": "Evidence",
          "display": "Ethnicity (NIH/OMB) for Glucagon Hydrochloride Solution/Glucagon Nasal Powder at baseline in NCT03421379"
        },
        {
          "reference": "#NCT03421379-BaselineMeasure-2-BG002",
          "type": "Evidence",
          "display": "Ethnicity (NIH/OMB) for Total at baseline in NCT03421379"
        }
      ],
      "section": [
        {
          "title": "Baseline Measure Calculate Percent",
          "code": {
            "text": "BaselineMeasureCalculatePct"
          },
          "text": {
            "status": "generated",
            "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">False</div>"
          }
        }
      ]
    },
    {
      "title": "Race (NIH/OMB)",
      "code": {
        "coding": [
          {
            "system": "https://fevir.net/resources/CodeSystem/179423",
            "code": "results",
            "display": "Results"
          }
        ]
      },
      "focus": {
        "reference": "#NCT03421379-BaselineMeasure-3",
        "type": "EvidenceVariable",
        "display": "Race (NIH/OMB)"
      },
      "text": {
        "status": "empty",
        "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No data.]</p></div>"
      },
      "entry": [
        {
          "reference": "#NCT03421379-BaselineMeasure-3-BG000",
          "type": "Evidence",
          "display": "Race (NIH/OMB) for Glucagon Nasal Powder/Glucagon Hydrochloride Solution at baseline in NCT03421379"
        },
        {
          "reference": "#NCT03421379-BaselineMeasure-3-BG001",
          "type": "Evidence",
          "display": "Race (NIH/OMB) for Glucagon Hydrochloride Solution/Glucagon Nasal Powder at baseline in NCT03421379"
        },
        {
          "reference": "#NCT03421379-BaselineMeasure-3-BG002",
          "type": "Evidence",
          "display": "Race (NIH/OMB) for Total at baseline in NCT03421379"
        }
      ],
      "section": [
        {
          "title": "Baseline Measure Calculate Percent",
          "code": {
            "text": "BaselineMeasureCalculatePct"
          },
          "text": {
            "status": "generated",
            "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">False</div>"
          }
        }
      ]
    },
    {
      "title": "Region of Enrollment",
      "code": {
        "coding": [
          {
            "system": "https://fevir.net/resources/CodeSystem/179423",
            "code": "results",
            "display": "Results"
          }
        ]
      },
      "focus": {
        "reference": "#NCT03421379-BaselineMeasure-4",
        "type": "EvidenceVariable",
        "display": "Region of Enrollment"
      },
      "text": {
        "status": "empty",
        "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No data.]</p></div>"
      },
      "entry": [
        {
          "reference": "#NCT03421379-BaselineMeasure-4-BG000",
          "type": "Evidence",
          "display": "Region of Enrollment for Glucagon Nasal Powder/Glucagon Hydrochloride Solution at baseline in NCT03421379"
        },
        {
          "reference": "#NCT03421379-BaselineMeasure-4-BG001",
          "type": "Evidence",
          "display": "Region of Enrollment for Glucagon Hydrochloride Solution/Glucagon Nasal Powder at baseline in NCT03421379"
        },
        {
          "reference": "#NCT03421379-BaselineMeasure-4-BG002",
          "type": "Evidence",
          "display": "Region of Enrollment for Total at baseline in NCT03421379"
        }
      ]
    }
  ]
}